Haeberlin, Andreas; Ploux, Sylvain; Noel, Antoine; Chauvel, Rémi; Welte, Nicolas; Marchand, Hugo; Haissaguerre, Michel; Ritter, Philippe; Bordachar, Pierre (2019). Left ventricular sensing in cardiac resynchronization devices-opportunities and pitfalls for device programming. Journal of cardiovascular electrophysiology, 30(8), pp. 1352-1361. Wiley-Blackwell 10.1111/jce.14039
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
Haeberlin_et_al-2019-Journal_of_Cardiovascular_Electrophysiology.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (2MB) | Request a copy |
INTRODUCTION
Some cardiac resynchronization therapy (CRT) device manufacturers (Biotronik, Germany; Boston Scientific, United States) have implemented left ventricular (LV) sensing functionality to prevent pacing into the vulnerable phase. Physicians are only partially aware of programming pitfalls related to LV sensing and general programming advice is lacking.
METHODS AND RESULTS
We provide an illustrative case-series-based review of the variety of potential problems with LV sensing. LV sensing may inappropriately impair CRT delivery due to LV-sensing issues or improper device programming. This can cause beat-wise loss of resynchronization but also ongoing desynchronization. On the other hand, LV sensing provides additional diagnostic information, which may reveal intermittent problems of the LV lead such as capture loss. We summarize the available evidence to provide manufacturer-specific recommendations on device programming and troubleshooting for daily clinical practice.
CONCLUSION
CRT devices with LV sensing may suffer from impaired resynchronization due to programming pitfalls. If LV sensing is active (nominal setting in Biotronik and Boston Scientific devices), careful lookout for related problems and resynchronization percentage is required. Optimization is mandatory and even deactivation of LV sensing may have to be considered.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology 04 Faculty of Medicine > Faculty Institutions > sitem Center for Translational Medicine and Biomedical Entrepreneurship > Cardiac Technology and Implantable Devices 04 Faculty of Medicine > Faculty Institutions > sitem Center for Translational Medicine and Biomedical Entrepreneurship |
UniBE Contributor: |
Häberlin, Andreas David Heinrich |
Subjects: |
600 Technology > 610 Medicine & health 500 Science > 570 Life sciences; biology |
ISSN: |
1045-3873 |
Publisher: |
Wiley-Blackwell |
Language: |
English |
Submitter: |
Andreas Häberlin |
Date Deposited: |
08 Oct 2019 10:14 |
Last Modified: |
05 Dec 2022 15:31 |
Publisher DOI: |
10.1111/jce.14039 |
PubMed ID: |
31231884 |
Uncontrolled Keywords: |
cardiac resynchronization therapy left ventricular lead left ventricular sensing lock-in |
BORIS DOI: |
10.7892/boris.133743 |
URI: |
https://boris.unibe.ch/id/eprint/133743 |
Actions (login required)
 |
Edit item |